DR. SOFIE DE BLAUWE (0505.829.066): financials and annual accounts

DR. SOFIE DE BLAUWE

Bruges ·KBO/BCE: BE 0505.829.066

Line	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Balance sheet: assets
Total assets`20/58`	281,639	491,802	637,697	507,602	533,404	395,901	506,130	414,064	294,563	228,070	113,864
Fixed assets`21/28`	24,968	42,632	13,325	14,065	17,861	43,224	11,673	7,761	8,974	8,221	160
Tangible fixed assets`22/27`	24,968	42,632	13,325	14,065	17,861	43,224	11,673	7,761	8,974	8,221	160
Plant, machinery and equipment`23`	4,743	8,851	13,325	14,065	17,861	15,259	11,673	7,761	8,974	8,221	160
Furniture and vehicles`24`	20,224	33,781	-	-	-	27,966	-	-	-	-	-
Current assets`29/58`	256,671	449,170	624,372	493,537	515,543	352,676	494,457	406,304	285,590	219,849	113,704
Amounts receivable within one year`40/41`	1,735	11,094	26,618	17,409	18,813	5,090	465	-	-	-	2,052
Trade receivables`40`	0	1,318	26,618	17,409	14,032	-	465	-	-	-	2,052
Other amounts receivable`41`	1,735	9,776	-	-	4,782	5,090	-	-	-	-	-
Cash at bank and in hand`54/58`	253,021	436,334	597,199	476,086	496,729	347,549	493,992	406,304	285,590	219,849	111,652
Deferred charges and accrued income`490/1`	1,915	1,743	555	43	-	38	-	-	-	-	-
Balance sheet: equity and liabilities
Total equity and liabilities`10/49`	281,639	491,802	637,697	507,602	533,404	395,901	506,130	414,064	294,563	228,070	113,864
Equity`10/15`	18,600	100,843	313,681	493,940	377,319	389,901	479,615	355,644	238,608	152,403	73,270
Contributions`10/11`	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	12,500
Issued capital`100`	-	-	-	-	-	-	18,600	18,600	18,600	18,600	18,600
Uncalled capital`101`	-	-	-	-	-	-	-	-	-	-	6,100
Reserves`13`	0	12,321	12,321	12,321	12,321	12,321	12,321	9,331	6,555	1,860	1,860
Non-distributable reserves`130/1`	-	-	-	1,860	1,860	1,860	-	-	-	-	-
Legal reserve`130`	-	-	-	-	-	-	1,860	1,860	1,860	1,860	1,860
Reserves not available under the articles`1311`	-	-	-	1,860	1,860	1,860	-	-	-	-	-
Tax-exempt reserves`132`	0	10,461	10,461	10,461	10,461	10,461	10,461	7,471	4,695	-	-
Distributable reserves`133`	0	1,860	1,860	-	-	-	-	-	-	-	-
Profit (loss) carried forward`14`	0	69,922	282,760	463,019	346,398	358,980	448,695	327,713	213,452	131,943	58,910
Amounts payable`17/49`	263,039	390,959	324,017	13,662	156,085	6,000	26,515	58,420	55,956	75,667	40,594
Amounts payable within one year`42/48`	259,987	389,482	321,438	13,550	155,976	6,000	26,515	58,420	55,206	75,667	37,694
Trade debts`44`	540	5,492	3,370	2,500	2,500	2,500	3,025	-	1,500	593	-
Suppliers`440/4`	540	5,492	3,370	2,500	2,500	2,500	3,025	-	1,500	593	-
Taxes, remuneration and social security`45`	2,254	2,444	10,444	6,993	6,690	3,500	6,725	41,052	37,827	58,885	26,750
Taxes`450/3`	2,254	2,444	10,444	6,993	6,690	3,500	6,725	41,052	37,827	58,885	26,750
Other amounts payable`47/48`	257,194	381,545	307,624	4,057	146,786	-	16,765	17,368	15,879	16,189	10,944
Accrued charges and deferred income`492/3`	3,051	1,477	2,578	112	109	-	-	-	750	-	2,900
Income statement
Non-recurring operating income`76A`	-	-	-	-	21,965	-	-	-	-	-	-
Gross operating margin`9900`	260,077	209,622	198,425	155,374	173,719	148,169	165,852	155,081	128,078	107,509	86,964
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets`630`	17,665	11,364	4,129	3,796	2,869	6,078	2,056	1,717	1,628	1,309	79
Other operating charges`640/8`	574	503	975	519	511	511	509	505	508	606	152
Operating profit (loss)`9901`	241,838	197,755	193,321	151,059	170,338	141,579	163,287	152,859	125,942	105,595	86,733
Financial income`75/76B`	0	-	-	-	-	-	-	-	-	-	83
Recurring financial income`75`	0	-	-	-	-	-	-	-	-	-	83
Financial charges`65/66B`	3,215	72	204	72	72	78	816	822	811	562	46
Recurring financial charges`65`	3,215	72	204	72	72	78	816	822	811	562	46
Profit (loss) for the period before taxes`9903`	238,624	197,683	193,116	150,987	170,266	141,502	162,471	152,037	125,131	105,033	86,770
Income taxes`67/77`	58,265	45,520	43,376	34,365	37,848	31,217	38,500	35,000	38,927	32,000	26,000
Profit (loss) for the period`9904`	180,359	152,162	149,741	116,622	132,418	110,285	123,971	117,037	86,204	73,033	60,770
Transfer from tax-exempt reserves`789`	10,461	-	-	-	-	-	-	-	-	-	-
Transfer to tax-exempt reserves`689`	-	-	-	-	-	-	2,989	2,776	4,695	-	-
Profit (loss) for the period to be appropriated`9905`	190,819	152,162	149,741	116,622	132,418	110,285	120,982	114,261	81,509	73,033	60,770
Appropriation of the result
Profit (loss) to be appropriated`9906`	260,742	434,922	612,760	463,019	491,398	558,980	448,695	327,713	213,452	131,943	60,770
Profit (loss) brought forward from the previous period`14P`	69,922	282,760	463,019	346,398	358,980	-	-	-	-	-	-
Transfer from equity`791/2`	1,860	-	-	-	-	-	-	-	-	-	-
Transfer to equity`691/2`	-	-	-	-	-	-	-	-	-	-	1,860
To the legal reserve`6920`	-	-	-	-	-	-	-	-	-	-	1,860
Profit to be distributed`694/7`	262,602	365,000	330,000	-	145,000	200,000	-	-	-	-	-
Return on contributions (dividend)`694`	262,602	365,000	330,000	-	145,000	200,000	-	-	-	-	-
Document	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF

Financial year	Type	Filed	Reference	Document
31-12-2025	micro format	04-06-2026	2026-00141280	PDF
31-12-2024	micro format	28-07-2025	2025-00314432	PDF
31-12-2023	micro format	04-07-2024	2024-00205978	PDF
31-12-2022	micro format	29-06-2023	2023-00187763	PDF
31-12-2021	micro format	03-08-2022	2022-20267729	PDF
31-12-2020	micro format	28-07-2021	2021-42900127	PDF
31-12-2019	micro format	21-09-2020	2020-54800283	PDF
31-12-2018	micro format	04-07-2019	2019-29600272	PDF
31-12-2017	micro format	28-08-2018	2018-52400357	PDF
31-12-2016	micro format	26-06-2017	2017-21700382	PDF
31-12-2015	abbreviated format	23-08-2016	2016-45300538	PDF

Line	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
EBITDA	259,503	209,118	197,449	154,855	173,207	147,658	165,344	154,576	127,569	106,903	86,812
Cash flow	198,023	163,526	153,869	120,418	135,287	116,364	126,028	118,754	87,832	74,342	60,849
Investment in fixed assets (approximation)	0	40,671	3,389	0	5,472	37,629	5,969	504	2,380	9,370	239
Change in cash	-183,312	-160,865	121,113	-20,643	149,180	-146,443	87,688	120,714	65,741	108,197	-
Working capital	-3,316	59,688	302,934	479,987	359,566	346,676	467,942	347,884	230,384	144,182	76,010
Solvency	6.6%	20.5%	49.2%	97.3%	70.7%	98.5%	94.8%	85.9%	81.0%	66.8%	64.3%
Current ratio	0.99	1.15	1.94	36.42	3.31	58.78	18.65	6.95	5.17	2.91	3.02
Debt to equity	14.14	3.88	1.03	0.03	0.41	0.02	0.06	0.16	0.23	0.50	0.55
ROE	969.7%	150.9%	47.7%	23.6%	35.1%	28.3%	25.8%	32.9%	36.1%	47.9%	82.9%
ROA	64.0%	30.9%	23.5%	23.0%	24.8%	27.9%	24.5%	28.3%	29.3%	32.0%	53.4%
Interest coverage	80.73	over 100	over 100	over 100	over 100	-	-	-	-	-	-

Item	2025	2024	2023	2022	2021
Tangible fixed assets	-	€40,671	€3,389	-	€5,472
Depreciation and write-downs of the year	€17,665	€11,364	€4,129	€3,796	€2,869

DR. SOFIE DE BLAUWE

Annual accounts 2025

Balance sheet

Change in equityin euro

Change in cashin euro

Position in the sector

Solvency6.6%

Current ratio0.99

Return on assets64.0%

Filed annual accounts

Filings

Key figures and ratios

Investments

Insights on DR. SOFIE DE BLAUWE

Next steps